2 results
Approved WMORecruitment started
This PIONEER IV trial aims to demonstrate a non-inferiority of QFR-guidance PCI to usual care PCIwith respect to Patient oriented Composite Endpoint (PoCE) at 1 year with the unrestricted use ofHT Supreme-SES in an all-comers…
Approved WMOPending
The primary objective is to study whether a microparticulated whey protein shake shows a non-inferior incremental area under the curve (iAUC) of the plasma total essential amino acids (TEAA), up to 300 minutes after protein consumption, compared to…